Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Polyhydroxyalkanoates as promising materials in biomedical systems
KTH, School of Engineering Sciences in Chemistry, Biotechnology and Health (CBH), Fibre- and Polymer Technology.ORCID iD: 0000-0002-7790-8987
Show others and affiliations
2017 (English)In: Frontiers in Drug Design and Discovery, no 1, p. 242-288Article in journal (Refereed) Published
Abstract [en]

Polyhydroxyalkanoates (PHAs) are the natural polymers that have been a subject of a significant research interest in the past few decades. The PHAs (natural as well as their synthetic analogs) as biodegradable and biocompatible polymers were studied intensively for biomedical applications, that is, scaffolds for tissue engineering. Drug-loaded implants or scaffolds based on these polyesters were also used in the drug release systems. Drug delivery systems should provide an optimal release profile of an active compound that allows to increase therapeutic effect, decrease side effects, and improve patient convenience and compliance. Therefore, recently, the increasing interest is focused on the use of PHA as drug carriers because of significant improvement in the bioavailability of bioactive substances. Recent developments introduced such strategies as conjugation of the drug with low-molecular-weight poly(3-hydroxybutyrate) or preparation of PHA particles loaded with the drug. On the contrary, there is a growing interest in functionalized PHA technology. The advancement of these strategies allows to obtain the targeting systems based on the chemical modification, for example, by folic acid attachment or biosynthesis of targeting proteins on the PHA particle surface. In addition, the PHAs were presented as materials that could be used in transdermal administration of bioactive substances for medical or cosmetic purposes. The development of novel functionalized PHAs has opened new possibilities to combine good biocompatibility of PHA-based drug delivery systems with improved drug loading and release properties, targeting, or imaging possibilities. Further progress in PHA-based drug delivery systems is expected because of the combination of excellent biocompatibility of these biopolymers and strong beneficial effect on drug administration. 

Place, publisher, year, edition, pages
Bentham Science Publishers B.V. , 2017. no 1, p. 242-288
Keywords [en]
Conjugate, Drug delivery systems, Implants, Poly(3-hydroxybutyrate), Polyhydroxyalkanoates, Polymeric nanoparticles
National Category
Pharmaceutical Sciences
Identifiers
URN: urn:nbn:se:kth:diva-236841DOI: 10.2174/9781681083551117080007Scopus ID: 2-s2.0-85054069579OAI: oai:DiVA.org:kth-236841DiVA, id: diva2:1273713
Note

QC 20181221

Available from: 2018-12-21 Created: 2018-12-21 Last updated: 2018-12-21Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records BETA

Hakkarainen, Minna

Search in DiVA

By author/editor
Hakkarainen, Minna
By organisation
Fibre- and Polymer Technology
Pharmaceutical Sciences

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 85 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf